Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention

by Anthony T. Podany, Yajing Bao, Susan Swindells, Richard E. Chaisson, Janet W. Andersen, Thando Mwelase, Khuanchai Supparatpinyo, Lerato Mohapi, Amita Gupta, Constance A. Benson, Peter Kim, Courtney V. Fletcher
Published 2018

Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention

by Anthony T. Podany, Yajing Bao, Susan Swindells, Richard E. Chaisson, Janet W. Andersen, Thando Mwelase, Khuanchai Supparatpinyo, Lerato Mohapi, Amita Gupta, Constance A. Benson, Peter Kim, Courtney V. Fletcher
Published 2018

Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in adults living with HIV

by Lerato Mohapi, Yvett Pinedo, Olayemi Osiyemi, Khuanchai Supparatpinyo, Winai Ratanasuwan, Jean Michel Molina, Ron Dagan, Gretchen Tamms, Tina Sterling, Ying Zhang, Alison Pedley, Jon Hartzel, Yanqing Kan, Kim Hurtado, Luwy Musey, Jakub K. Simon, Ulrike K. Buchwald
Published 2022

An Evaluation of Baseline Kidney Function in the REPRIEVE Trial of Pitavastatin in Human Immunodeficiency Virus

by Edgar T. Overton, Amy Kantor, Kathleen V. Fitch, Paul Muntner, Khuanchai Supparatpinyo, Mosepele Mosepele, Lerato Mohapi, Sandra Wagner Cardoso, Sandesh Patil, Marcus V.G. de Lacerda, Grace McComsey, Judith A. Aberg, Pamela S. Douglas, Steven K. Grinspoon, Heather Ribaudo, Christina M. Wyatt
Published 2020

One month of rifapentine plus isoniazid to prevent HIV-related Tuberculosis

by Susan Swindells, Ritesh Ramchandani, Amita Gupta, Constance A. Benson, Jorge Leon-Cruz, Noluthando Mwelase, Marc A. Jean Juste, Javier R. Lama, Javier Valencia, Ayotunde Omoz-Oarhe, Khuanchai Supparatpinyo, Gaerolwe Masheto, Lerato Mohapi, Rodrigo O. Da Silva Escada, Sajeeda Mawlana, Peter Banda, Patrice Severe, James Hakim, Cecilia Kanyama, Deborah Langat, Laura Moran, Janet Andersen, Courtney V. Fletcher, Eric Nuermberger, Richard E. Chaisson
Published 2019

Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study

by Beatriz Grinsztejn, Michael D. Hughes, Justin Ritz, Robert Salata, Peter Mugyenyi, Evelyn Hogg, Linda Wieclaw, Robert Gross, Catherine Godfrey, Sandra W. Cardoso, Aggrey Bukuru, Mumbi Makanga, Sharlaa Faesen, Vidya Mave, Beatrice Wangari Ndege, Sandy Nerette Fontain, Wadzanai Samaneka, Rode Secours, Marije van Schalkwyk, Rosie Mngqibisa, Lerato Mohapi, Javier Valencia, Patcharaphan Sugandhavesa, Esmelda Montalban, Anchalee Avihingsanon, Breno R. Santos, Nagalingeswaran Kumarasamy, Cecilia Kanyama, Robert T. Schooley, John W. Mellors, Carole L. Wallis, Ann C. Collier, B. Grinsztejn, P. N. Mugyenyi, A. Collier, R. Salata, C. Godfrey, E. Hogg, M. Hughes, J. Ritz, L. Wieclaw, T. Sise, J. W. Mellors, C. Wallis, C. V. Fletcher, M. Gandhi, R. Gross, R. T. Schooley, R. Walensky, M. van Schalkwyk, S. Faesen, R. Mngqibisa, J. Valencia, E. Montalban, N. Kumarasamy, C. Kanyama, S. W. Cardoso, B. R. Santos, B. Mansfield, H. Mugerwa, B. W. Ndege, R. Secours, W. Samaneka, D. Kadam, V. Mave, M. Makanga, S. N. Fontain, P. Sugandhavesa, A. Avihingsanon, L. Nakibuuka, H. Nassolo, P. Anthony, V. Kulkarni, M. Nsubuga, J. van Wyk, J. Rooney, Y. van Delft, R. Leavitt, R. Luk, A. Benns, L. Hovind, A. Shahkolahi
Published 2019